HIV VACCINES - BACK TO PRIMARY-SCHOOL

[1] ENHANCEMENT OF SIV INFECTION WITH SOLUBLE RECEPTOR MOLECULES [J]. SCIENCE, 1990, 247 (4946) : 1084 - 1088

[2] ALLAN JS, 1991, SCIENCE, V252, P1322, DOI 10.1126/science.1925547

[3] CRYPTIC NATURE OF ENVELOPE V3 REGION EPITOPES PROTECTS PRIMARY MONOCYTOTROPIC HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 FROM ANTIBODY NEUTRALIZATION [J]. JOURNAL OF VIROLOGY, 1994, 68 (09) : 6006 - 6013

[4] HIGH-CONCENTRATIONS OF RECOMBINANT SOLUBLE CD4 ARE REQUIRED TO NEUTRALIZE PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATES [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (17) : 6574 - 6578

[5] TENTH ANNIVERSARY PERSPECTIVES ON AIDS - DILEMMA OF NEUTRALIZATION RESISTANCE OF HIV-1 FIELD ISOLATES AND VACCINE DEVELOPMENT [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (06) : 631 - 632

[6] MONTEFIORI DC, 1993, AIDS RES REV, V3, P161

[7] PRIMARY ISOLATES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ARE RELATIVELY RESISTANT TO NEUTRALIZATION BY MONOCLONAL-ANTIBODIES TO GP120, AND THEIR NEUTRALIZATION IS NOT PREDICTED BY STUDIES WITH MONOMERIC GP120 [J]. JOURNAL OF VIROLOGY, 1995, 69 (01) : 101 - 109

[8] VIRIONS OF PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATES RESISTANT TO SOLUBLE CD4 (SCD4) NEUTRALIZATION DIFFER IN SCD4 BINDING AND GLYCOPROTEIN GP120 RETENTION FROM SCD4-SENSITIVE ISOLATES [J]. JOURNAL OF VIROLOGY, 1992, 66 (01) : 235 - 243

[9] NAKAMURA GR, 1992, AIDS RES HUM RETROV, V8, P875

[10] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 NEUTRALIZATION IS DETERMINED BY EPITOPE EXPOSURE ON THE GP120 OLIGOMER [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (01) : 185 - 196

[1] ENHANCEMENT OF SIV INFECTION WITH SOLUBLE RECEPTOR MOLECULES [J]. SCIENCE, 1990, 247 (4946) : 1084 - 1088

[2] ALLAN JS, 1991, SCIENCE, V252, P1322, DOI 10.1126/science.1925547

[3] CRYPTIC NATURE OF ENVELOPE V3 REGION EPITOPES PROTECTS PRIMARY MONOCYTOTROPIC HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 FROM ANTIBODY NEUTRALIZATION [J]. JOURNAL OF VIROLOGY, 1994, 68 (09) : 6006 - 6013

[4] HIGH-CONCENTRATIONS OF RECOMBINANT SOLUBLE CD4 ARE REQUIRED TO NEUTRALIZE PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATES [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (17) : 6574 - 6578

[5] TENTH ANNIVERSARY PERSPECTIVES ON AIDS - DILEMMA OF NEUTRALIZATION RESISTANCE OF HIV-1 FIELD ISOLATES AND VACCINE DEVELOPMENT [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (06) : 631 - 632

[6] MONTEFIORI DC, 1993, AIDS RES REV, V3, P161

[7] PRIMARY ISOLATES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ARE RELATIVELY RESISTANT TO NEUTRALIZATION BY MONOCLONAL-ANTIBODIES TO GP120, AND THEIR NEUTRALIZATION IS NOT PREDICTED BY STUDIES WITH MONOMERIC GP120 [J]. JOURNAL OF VIROLOGY, 1995, 69 (01) : 101 - 109

[8] VIRIONS OF PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATES RESISTANT TO SOLUBLE CD4 (SCD4) NEUTRALIZATION DIFFER IN SCD4 BINDING AND GLYCOPROTEIN GP120 RETENTION FROM SCD4-SENSITIVE ISOLATES [J]. JOURNAL OF VIROLOGY, 1992, 66 (01) : 235 - 243

[9] NAKAMURA GR, 1992, AIDS RES HUM RETROV, V8, P875

[10] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 NEUTRALIZATION IS DETERMINED BY EPITOPE EXPOSURE ON THE GP120 OLIGOMER [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (01) : 185 - 196